This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Arcutis Biotherapeutics, Inc., Brickell Biotech, Inc., Kaken Pharmaceutical Company, Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 28 
1 out of 3 
1 out of 136 
Years Active: 2024-2026
Title: Herbert R Brinkman: Innovator in Pharmaceutical Formulations
Introduction
Herbert R Brinkman is a notable inventor based in Fort Collins, Colorado. He has made significant contributions to the field of pharmaceutical formulations, particularly with his work on stable compositions of SHR0302.
Latest Patents
Brinkman holds a patent for "Stable formulations of SHR0302." This patent discloses stable topical pharmaceutical compositions of SHR0302, also known as ARQ-250. The formulations are designed to maintain a pH of less than about 4.6, which improves stability and prevents crystal formation of the active pharmaceutical ingredient (API). Additionally, the compositions that include about 20% to about 30% dimethyl sulfoxide (DMSO) also demonstrate enhanced stability. These improved formulations can exhibit an acceptable commercial product shelf life without loss of potency after prolonged storage.
Career Highlights
Brinkman is currently associated with Arcutis Biotherapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing formulations that enhance the efficacy and stability of topical treatments.
Collaborations
Brinkman collaborates with Jason Michael Carbol, contributing to advancements in pharmaceutical research and development.
Conclusion
Herbert R Brinkman is a key figure in the development of stable pharmaceutical formulations, with a focus on improving the stability and efficacy of topical treatments. His contributions are vital to the ongoing advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile